Alkermes plc (ALKS) vs Cytokinetics, Incorporated (CYTK)
A side-by-side comparison of Alkermes plc and Cytokinetics, Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALKS
Alkermes plc
$42.64HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CYTK
Cytokinetics, Incorporated
$62.10HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — ALKS vs CYTK
growth of $100 · dividends reinvested · last 10yALKS -7.3% (-0.8%/yr)CYTK +570.6% (+21.0%/yr)CYTK compounded faster over this window
Log scale — wide-divergence pair
ALKS CYTK
ALKS vs CYTK: by the numbers
- •CYTK is the larger company ($7.73B vs $7.15B market cap).
- •ALKS is profitable (3.97% net margin) while CYTK runs a net loss (-1259.87%).
- •ALKS grew revenue faster over the past five years (8.68% vs 4.19% CAGR).
Metrics side by side
Valuation
| Metric | ALKS | CYTK |
|---|---|---|
| P/E ratio | 111.33 | N/A |
| P/S ratio | 4.29 | 108.90 |
| P/B ratio | 3.96 | N/A |
| EV / EBITDA | 45.91 | N/A |
| FCF yield | 3.10% | N/A |
Profitability
| Metric | ALKS | CYTK |
|---|---|---|
| Gross margin | 84.56% | 84.97% |
| Operating margin | 17.21% | -695.44% |
| Net margin | 3.97% | -1259.87% |
| ROE | 3.66% | N/A |
| ROIC | 2.12% | -39.80% |
Growth (annualized)
| Metric | ALKS | CYTK |
|---|---|---|
| Revenue CAGR (5Y) | 8.68% | 4.19% |
| FCF CAGR (5Y) | 20.00% | N/A |
| Total return CAGR (5Y) | 6.73% | 11.24% |
Frequently asked
- Which has grown faster, ALKS or CYTK?
- Over the past five years, ALKS grew revenue faster — ALKS at a 8.68% CAGR versus CYTK at 4.19%.
- Is ALKS or CYTK more profitable?
- ALKS runs the higher net margin — ALKS at 3.97% versus CYTK at -1259.87%.
- How have ALKS and CYTK total returns compared?
- Over the past 10 years, ALKS delivered -0.82% and CYTK delivered 20.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alkermes P/E ratioAlkermes ROECytokinetics ROEAlkermes operating marginCytokinetics operating marginAlkermes revenue growthCytokinetics revenue growthAlkermes free cash flowCytokinetics free cash flow
Alkermes & Cytokinetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.